Cargando…
HLA class II and rheumatoid arthritis: the bumpy road of revelation
Rheumatoid arthritis (RA) is a chronic auto-immune disease primarily targeting the joints. Approximately 1% of the population is affected by RA, and despite the improvements in therapeutic interventions, elucidation of the disease pathogenesis is still in its infancy. RA patients can be subdivided o...
Autores principales: | Kampstra, Arieke S.B., Toes, René E.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537318/ https://www.ncbi.nlm.nih.gov/pubmed/28695293 http://dx.doi.org/10.1007/s00251-017-0987-5 |
Ejemplares similares
-
Ligandomes obtained from different HLA-class II-molecules are homologous for N- and C-terminal residues outside the peptide-binding cleft
por: Kampstra, Arieke S.B., et al.
Publicado: (2019) -
Absence of Epstein-Barr virus DNA in anti-citrullinated protein antibody-expressing B cells of patients with rheumatoid arthritis
por: Kroos, Sanne, et al.
Publicado: (2022) -
The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules
por: Kampstra, Arieke S. B., et al.
Publicado: (2016) -
On the bumpy road towards ‘personalized medicine’
por: Francke, Uta
Publicado: (2010) -
Malaria Vaccines: Progressing on a Bumpy Road
por: Corradin, Giampietro, et al.
Publicado: (2014)